Cecilia Luz Balderas-Vazquez

Dr. Cecilia Luz Balderas-Vazquez

orcid
Universidad Anáhuac Veracruz, Campus Córdoba-Orizaba

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2025 in Neurology International
Verified
Journal Article
Open access
PDF file
MHMargarita Hernandez-Mixteco
Margarita Hernandez-Mixteco
OVOlga Valenzuela
Olga Valenzuela
Cecilia Luz Balderas-VazquezCecilia Luz Balderas-Vazquez
Cecilia Luz Balderas-Vazquez
PCPaola Castillo-Juárez
Paola Castillo-Juárez
SGSandra Rivera Gutierrez
Sandra Rivera Gutierrez
JCJorge Francisco Francisco Cerna Cortes
Jorge Francisco Francisco Cerna Cortes
Background: Depression is one of the most prevalent mental health disorders worldwide, affecting a significant proportion of the global population. Its etiology is complex and influenced by the interaction of environmental factors and genetic variations. In Mexico, it has been reported that 41.3% of the population exhibits depressive symptoms. Previous studies have suggested that susceptibility to depression may be associated with the C-1019G (rs6295) polymorphism in the serotonin 1A (5-HT1A) receptor gene. Objective: In this study, we aimed to evaluate the association between the C-1019G polymorphism and depressive symptoms in a rural Mexican population. Methods: Using polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP), we examined the effect of C-1019G on depression symptoms, as evaluated by the Beck Depression Inventory. Data were obtained from 83 volunteers; individuals with depressive symptoms and those with a healthy mood were compared. Results: The results showed that the homozygous C/C genotype was found significantly more frequently in the control group than in individuals with depressive symptoms, particularly among men, and is thus associated with a decreased risk of depressive symptomatology. Conclusions: The C/C genotype could protect against susceptibility to developing depressive symptoms in a rural population in Mexico.

21 June 2025 in Quimiofilia
Verified
Journal Article
Closed access
UCUniversidad Veracruzana. Xalapa Maestría En Farmacia Clínica
Universidad Veracruzana. Xalapa Maestría En Farmacia Clínica
JCJorge Alberto Carballo-Juárez
Jorge Alberto Carballo-Juárez
UBUniversidad Veracruzana. Xalapa Facultad de Química Farmacéutica Biológica
Universidad Veracruzana. Xalapa Facultad de Química Farmacéutica Biológica
ASAdolfo Sánchez-Flores
Adolfo Sánchez-Flores
UMUniversidad Veracruzana. Orizaba Cuerpo Académico 214 “Farmacología Clínica Y Molecular
Universidad Veracruzana. Orizaba Cuerpo Académico 214 “Farmacología Clínica Y Molecular
EHEmma Virginia Herrera-Huerta
Emma Virginia Herrera-Huerta
La resistencia antimicrobiana (RAM) es una amenaza creciente para la salud pública y el medio ambiente. La eliminación inadecuada de antimicrobianos en aguas residuales hospitalarias contribuye a su presencia en cuerpos de agua, favoreciendo microorganismos resis-tentes. Este artículo examina la asociación entre la contaminación ambiental y la diseminación de la RAM, así como las limitaciones del marco normativo vigente en México. Se ofrece un análisis crítico de este vacío normativo y se plantean recomendaciones de acción frente a la resistencia antimicrobiana ambiental, desde una perspec-tiva conjunta de salud pública y sostenibilidad ambiental.